---
category: news
title: "The high stakes of pricing a coronavirus drug"
excerpt: "Gilead's pricing decision is important on its own, but it also will set the bar for how all coronavirus treatments that come after remdesivir will be priced. Where it stands: Gilead CEO Daniel O'Day has punted all questions related to remdesivir's price thus far."
publishedDateTime: 2020-05-07T09:34:00Z
webUrl: "https://www.axios.com/remdesivir-gilead-drug-pricing-coronavirus-dc25472c-6c0f-4476-8858-41466ddeabce.html"
ampWebUrl: "https://www.axios.com/remdesivir-gilead-drug-pricing-coronavirus-dc25472c-6c0f-4476-8858-41466ddeabce.html"
cdnAmpWebUrl: "https://www-axios-com.cdn.ampproject.org/c/s/www.axios.com/remdesivir-gilead-drug-pricing-coronavirus-dc25472c-6c0f-4476-8858-41466ddeabce.html"
type: article
quality: 75
heat: 75
published: false

provider:
  name: Axios
  domain: axios.com

topics:
  - Treatment
  - Coronavirus

images:
  - url: "https://images.axios.com/09AuXQJvH2kfO0p0fTYS9LMpSEQ=/2020/05/06/1588783132926.jpg"
    width: 1920
    height: 1080
    title: "The high stakes of pricing a coronavirus drug"

secured: "OAJVtUT9eSME4Eg4gvZcBhC0JzvH5fLv+Nf6gH3sJeLFtNMNDysv3mX8l/zqa6/0/bldWCxn2g42Flsca2F/B0pzyGC/nfncOwRIJSAbDvvSNoYHS1+nTOSdNiLBJUl8n2EDpCd0M/tnipfYNgmvI3c8Vc1zul0mn4MbbdzimpkZARJxGb7PuXQsBlIAD62CJu/OkH1QlD+4ped847/147nn+46qX9wpPzw2ggBs4INngGXXC+1ZWJndwObGVXZhVxy/WwQcDYp+0emQ5Xkp3M+d5OWHMiiYL4kK0HeqfbgI0cZyaH9Yv/CwDNIWXIMR;UKw7kumNWm1b5yIsCY/AyA=="
---

